Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)

NCT03533582 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT03533582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03533582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Active, not recruiting
Start date
May 24, 2018
Completion date
March 31, 2027
Enrollment
537 (estimated)
Sites
205

Conditions

As the registry lists them; a condition with its own page is linked.

childhood hepatocellular carcinoma, childhood malignant liver neoplasm, fibrolamellar carcinoma, hepatoblastoma, hepatocellular malignant neoplasm, not otherwise specified